Pawel Kalinsky: Just-concluded the 2025 Marie Sklodowska-Curie Symposium on Cancer Research and Care

Pawel Kalinsky shared on LinkedIn:

“Congratulations to All Participants of the just-concluded 2025 Marie Sklodowska-Curie Symposium on Cancer Research and Care on the fantastic three days of discussions of how to work together more effectively across the Atlantic.

Special thanks to our Sponsors, Organizing Team and all presenters from NCI, CDC, NYS ESD, Poland’s NIO and Medical Research Agency, as well as their colleagues from Ukraine, Canada, Romania, Croatia, Lithuania and other CEE Countries, for making this meeting a success and for productive discussions on cancer prevention, early detection, early-phase clinical trials, training and mentoring, and the emerging venues to improve the cure rates and the quality of life of patients with cancer.

I look forward to the next year meeting organized by Prof. Piotr Rutkowski and Prof. Iwona Lugowska, in Warsaw, September 4-6, 2025.”

Read Further.
Source: Pawel Kalinsky/LinkedIn

Pawel Kalinski, M.D., Ph.D., serves as the Vice Chair for Translational Research and is a Professor of Oncology in the Department of Medicine at Roswell Park Cancer Institute (RPCI) in Buffalo, NY. He also directs Cancer Vaccine and Dendritic Cell Therapies at the Center for Immunotherapy and co-leads the Tumor Immunology & Immunotherapy Program at RPCI.

Dr. Kalinski is a member of several professional organizations, including the Society for Immunotherapy of Cancer (SITC), the American Association of Immunologists (AAI), the American Association for Cancer Research (AACR), and the American Society of Clinical Investigation (ASCI). He is also an editorial board member for multiple journals focused on cancer immunology and immunotherapy. Recently, he has received several grants from the National Cancer Institute. With over 130 publications in immunology and cancer research, his work has been cited more than 5,500 times.